| Financial Year |
March 31 2023 |
| Monetary Funds |
1,300,031,351.39 |
| Held-for-trading Financial Assets |
412,234,583.88 |
| Notes Receivable |
-- |
| Accounts Receivable |
875,831,204.42 |
| Advances to Suppliers |
86,590,265.27 |
| Other Receivables |
74,481,831.90 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
992,855,374.06 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
42,875,419.89 |
| Other Current Assets |
86,165,604.69 |
| Total Current Assets |
3,955,697,463.64 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
115,640.37 |
| Long-term Equity Investment |
147,528,478.56 |
| Investment Properties |
-- |
| Fixed Assetes |
489,510,330.16 |
| Under-construction Projects |
187,548,086.91 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
230,111,281.27 |
| R&D expenses |
-- |
| Goodwill |
4,201,697.40 |
| Long-Term Deferred and Prepaid Expenses |
22,268,977.65 |
| Deferred Income Tax Assets |
63,793,656.96 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
1,597,149,706.35 |
| Total Assets |
5,552,847,169.99 |
| Short-Term Loans |
519,629,007.33 |
| Trading Financial liabilities |
3,129,708.07 |
| Notes Payable |
913,585,923.60 |
| Accounts Payable |
666,875,931.95 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
37,511,873.05 |
| Taxes Payable |
42,006,293.05 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
70,585,841.31 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
66,051,203.21 |
| Other Current Liabilities |
15,880,406.71 |
| Sub-Total of Current Liabilities |
2,370,234,849.56 |
| Long-term Loans |
182,912,276.39 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
17,419,736.76 |
| Deferred Income Tax Liabilities |
86,193,137.41 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
415,654,192.90 |
| Total Liabilities |
2,785,889,042.46 |
| Paid-In Capital(Or Share Stock) |
384,214,913.00 |
| Capital Surplus |
1,809,337,643.36 |
| Surplus Reserve |
70,308,241.63 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
419,402,229.36 |
| Minority Stockholder's Interest |
100,379,044.55 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,666,579,082.98 |
| Owner's Equity（Stockholder's Equity） |
2,766,958,127.53 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,552,847,169.99 |
